Private equity firm EQT increases offer for Sweden's Karo Pharma

STOCKHOLM, Jan 2 (Reuters) - Private equity firm EQT on Wednesday bumped up its offer for Swedish specialty pharma group Karo Pharma to 6.15 billion Swedish crowns ($694 million), citing in part stock market performance since its original offer two months ago.